NHS Logo

Nutritional and therapeutic interventions for diabetes and metabolic syndrome (Record no. 90404)

MARC details
000 -LEADER
fixed length control field 06830cam a2200781Ia 4500
001 - CONTROL NUMBER
control field ocn778434968
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240821185839.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120128s2012 ne adf ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency E7B
019 ## -
-- 778314639
-- 817056798
-- 823131521
-- 824106855
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9780123850836
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 0123850835
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9780123850843
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 0123850843
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1283434105
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781283434102
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9780123850836
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 0123850835
035 ## - SYSTEM CONTROL NUMBER
System control number 453807
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)778434968
Canceled/invalid control number (OCoLC)778314639
-- (OCoLC)817056798
-- (OCoLC)823131521
-- (OCoLC)824106855
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number 2012 C-430
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number WK 810
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039050
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Nutritional and therapeutic interventions for diabetes and metabolic syndrome
Statement of responsibility, etc
Medium [E-Book]
250 ## - EDITION
Edition statement 1st ed.
260 ## - PUBLICATION INFORMATION
Place of publication Amsterdam ;
-- Boston :
Publisher Elsevier/Academic Press,
Date 2012.
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource (xvi, 523 pages, 12 unnumbered pages of plates) :
Other physical details illustrations (some color)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - CONTENTS
Contents Epidemiology and overview -- Type 1 diabetes mellitus: an overview -- An overview on type 2 diabetes -- Pathogenesis of type 2 diabetes-: a comprehensive analysis -- Managing the broad spectrum of type 2 diabetes -- Prediabetes: prevalence, pathophysiology and recognition of enhanced risk -- Obesity and type 2 diabetes in youths: new challenges to overcome -- Diabetes pathophysiology- a nutritional perspective -- Diabetes pathophysiology- a nurse's perspective -- Roles of environmental pollution and pesticides in the metabolic syndrome and diabetes: the epidemiological evidence -- Preventing diabetes with diet and exercise -- Types of diabetes and its correlation with other diseases -- The role of insulin resistance in the cardiorenal syndrome -- An overview on diabetic nephropathy -- An overview on diabetes and ocular health -- An overview on diabetic retinopathy -- Role of peripheral neuropathy in the development of foot ulceration and impaired wound healing in diabetes mellitus -- An overview on gestational diabetes -- Molecular insights of diabetes and metabolic syndrome -- Gene-environment interaction in the pathogenesis of type 2 diabetes -- Epigenetics in the pathophysiology of type 2 diabetes -- Targeting the metabolic syndrome and type 2 diabetes by preventing inflammation -- Interleukin-18 in metabolic syndrome and diabetes -- Pathophysiology -- Sleep, hypertension and diabetes -- Roles of pancreatic cell functions, liver, skeletal muscle and adipose tissues in diabetes and metabolic syndrome -- Liver disease: a neglected complication of diabetes mellitus -- Prevention and treatment 1: diet, exercise, supplements and alternative medicines -- Antioxidants, healthy diet and diabetes -- Molecular mechanisms of diabetes prevention by structurally diverse antioxidants -- Cardioprotective roles of selenium in diabetes -- Exercise and physical activity in the prevention of diabetes and metabolic syndrome -- An overview on nutraceuticals and herbal supplements for diabetes and metabolic syndrome -- Therapeutic effect of fucoxanthin on metabolic syndrome and type 2 diabetes -- Beneficial effects of chromium (iii) and vanadium supplements in diabetes -- Role of n-6 and n-3 polyunsaturated fatty acids in type 2 diabetes -- Effects of supplemental fiber in type 2 diabetes mellitus -- The effects of resveratrol on diabetes and obesity -- Meal plans for diabetics: caloric intake, calorie counting and glycemic index -- Ayurveda and metabolic diseases -- whole is greater than sum of parts -- Prevention and treatment 2: drugs and pharmaceuticals -- The evolution of glucose-lowering drugs for type 2 diabetes -- Anti-diabetic drugs for elderly population -- Diabetes in animals and treatment -- Diabetes mellitus in animals: diagnosis and treatment of diabetes mellitus in dogs and cats -- Overview of diabetes treatment in animals -- Living with diabetes: a running commentary.
520 ## - ABSTRACT
Abstract Diabetes mellitus affects approximately 20 million people in the US, or nearly 7% of the population. It is expected to increase by 70% within the next 25 years and numerous epidemiologic studies have demonstrated that type 2 diabetes increases the risk of cardiovascular morbidity and mortality. It is estimated to cost over $92 BILLION in health care costs and lost productivity. The increased risk is due to the detrimental vascular effects of prolonged exposure to a hyperglycemic, oxidant rich environment yielding associated cardiovascular risk factors: atherosclerosis, hypertension and clotting abnormalities. Hypertension and dyslipidemia in diabetic patients produces substantial decreases in cardiovascular and micro vascular diseases. Debasis Bagchi and Nair Sreejayan provides an overview of the current epidemic, outlines the consequences of this crisis and lays out strategies to forestall and prevent diabetes, obesity and other intricate issues of metabolic syndrome.
590 ## - LOCAL NOTE (RLIN)
Local note WorldCat record variable field(s) change: 650
650 #0 - SUBJECT HEADINGS
Subject term Diabetes
General subdivision Nutritional aspects.
650 #0 - SUBJECT HEADINGS
Subject term Diabetes
General subdivision Treatment.
650 #0 - SUBJECT HEADINGS
Subject term Metabolic syndrome
General subdivision Nutritional aspects.
650 #0 - SUBJECT HEADINGS
Subject term Metabolic syndrome
General subdivision Treatment.
650 #0 - SUBJECT HEADINGS
Subject term Diabetes.
650 #2 - SUBJECT HEADINGS
Subject term Diabetes Mellitus
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term suikerziekte
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term diabetes
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term maatregel op voedingsgebied
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term nutritional intervention
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term ziektepreventie
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term disease prevention
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term dieetbehandeling
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term diet treatment
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term fysiopathologie
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term physiopathology
653 10 - INDEX TERM--UNCONTROLLED
Uncontrolled term Human Pathology
653 10 - INDEX TERM--UNCONTROLLED
Uncontrolled term Humane pathologie
700 1# - ADDED PERSONAL NAME
Added personal author Bagchi, Debasis,
700 1# - ADDED PERSONAL NAME
Added personal author Nair, Sreejayan.
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
347 ## - DIGITAL FILE CHARACTERISTICS
File type data file
Source rda
938 ## -
-- Coutts Information Services
-- COUT
-- 20691947
938 ## -
-- ebrary
-- EBRY
-- ebr10525056
938 ## -
-- EBSCOhost
-- EBSC
-- 453807
938 ## -
-- ProQuest MyiLibrary Digital eBook Collection
-- IDEB
-- 343410
938 ## -
-- YBP Library Services
-- YANK
-- 7364076
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library (Kingston Hospital) Stenhouse Library (Kingston Hospital) Online 28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=453807 28/11/2022 Electronic book